[Ticagrelor monotherapy in patients with acute coronary syndrome receiving new generation drug-eluting stents: results of the T-PASS randomized clinical trial]

G Ital Cardiol (Rome). 2024 Jun;25(6 Suppl 1):41S-42S. doi: 10.1714/4287.42692.
[Article in Italian]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Acute Coronary Syndrome* / therapy
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use
  • Purinergic P2Y Receptor Antagonists / administration & dosage
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Ticagrelor* / administration & dosage
  • Ticagrelor* / therapeutic use
  • Treatment Outcome

Substances

  • Ticagrelor
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors